Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Akuzawa

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neurogastroenterology and Motility|January 29, 2008
Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymerT Hirata, Y Keto, M Nakata, et al.
Digestive Diseases and Sciences|April 1, 1997
YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogsH Yuki, A Nishida, A Miyake, et al.
Neuropharmacology|June 1, 1995
Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortexH Ito, S Akuzawa, R Tsutsumi, et al.
Chemical & Pharmaceutical Bulletin|July 1, 1996
Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonistsM Satoh, Y Okamoto, H Koshio, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1997
YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivoY Takinami, H Yuki, A Nishida, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivoA Nishida, K Miyata, R Tsutsumi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in ratsA Nishida, Y Takinami, H Yuki, et al.
The American Journal of Physiology|November 1, 1995
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppressionA Nishida, A Kobayashi-Uchida, S Akuzawa, et al.
Arzneimittel-Forschung|June 3, 1998
Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistulaY Takemoto, H Yuki, A Nishida, et al.
Journal of Medicinal Chemistry|January 31, 1997
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonistG Semple, H Ryder, D P Rooker, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neurogastroenterology and Motility|January 29, 2008
Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymerT Hirata, Y Keto, M Nakata, et al.
Digestive Diseases and Sciences|April 1, 1997
YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogsH Yuki, A Nishida, A Miyake, et al.
Neuropharmacology|June 1, 1995
Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortexH Ito, S Akuzawa, R Tsutsumi, et al.
Chemical & Pharmaceutical Bulletin|July 1, 1996
Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonistsM Satoh, Y Okamoto, H Koshio, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1997
YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivoY Takinami, H Yuki, A Nishida, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivoA Nishida, K Miyata, R Tsutsumi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in ratsA Nishida, Y Takinami, H Yuki, et al.
The American Journal of Physiology|November 1, 1995
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppressionA Nishida, A Kobayashi-Uchida, S Akuzawa, et al.
Arzneimittel-Forschung|June 3, 1998
Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistulaY Takemoto, H Yuki, A Nishida, et al.
Journal of Medicinal Chemistry|January 31, 1997
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonistG Semple, H Ryder, D P Rooker, et al.
Pageof 3